UniCredit Aktienanleihe SNW 27.09.../ DE000HD13RE3 /
23/05/2024 17:56:30 | Chg.-0.16 | Bid23/05/2024 | Ask23/05/2024 | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
101.02EUR | -0.16% | 101.02 Bid Size: 100,000 |
101.11 Ask Size: 100,000 |
SANOFI SA INHABER ... | 75.00 - | 27/09/2024 | Call |
GlobeNewswire
21/05
Press Release: Sanofi, Formation Bio and OpenAI announce first-in-class AI collaboration
GlobeNewswire
20/05
Dupixent® (dupilumab) Late-Breaking Data from NOTUS Confirmatory Phase 3 COPD Trial Presented at ATS...
GlobeNewswire
20/05
Press Release: Dupixent® late-breaking data from NOTUS confirmatory phase 3 COPD study presented at ...
GlobeNewswire
20/05
Shah Capital Withdraws Proxy Campaign Against Re-Election of Directors at Novavax’s 2024 Annual Meet...
GlobeNewswire
13/05
Fulcrum Therapeutics Announces Recent Business Highlights and Financial Results for First Quarter 20...
GlobeNewswire
13/05
Fulcrum Therapeutics Enters into a Collaboration and License Agreement with Sanofi for the Developme...
GlobeNewswire
13/05
Dupixent® (dupilumab) sBLA Accepted for FDA Priority Review for Treatment of Adolescents with Chroni...
GlobeNewswire
10/05
Press Release: Sanofi and Novavax announce co-exclusive licensing agreement to co-commercialize COVI...
GlobeNewswire
08/05
IGM Biosciences Announces First Quarter 2024 Financial Results and Provides Corporate Update
GlobeNewswire
07/05
Denali Therapeutics Reports First Quarter 2024 Financial Results and Business Highlights
GlobeNewswire
02/05
Press Release: Beyfortus real-world evidence published in The Lancet shows 82% reduction in infant R...
GlobeNewswire
25/04
Press Release: Sanofi Q1: robust 7% sales growth driven by launches, underpins full-year guidance